Polymorphism, Genetic

Publication Title: 
Genes, Brain, and Behavior

Epigenetic mechanisms may moderate genetic and environmental risk (GxE) for mood disorders. We used an experimental rhesus macaque model of early life stress to test whether epigenetic regulation of serotonin transporter (5-HTT) may contribute to GxE interactions that influence behavior and emotion.

Author(s): 
Kinnally, E. L.
Capitanio, J. P.
Leibel, R.
Deng, L.
LeDuc, C.
Haghighi, F.
Mann, J. J.
Publication Title: 
Biological Psychiatry

BACKGROUND: Do genetic or epigenetic factors play a role in making some individuals more vulnerable than others to loss of attachment figures or other traumatic experiences? METHODS: DNA was obtained from growth phase entrained Epstein-Barr Virus (EBV) transformed lymphoblast cell lines from 143 adopted participants. Genotype of the serotonin transporter linked polymorphic region (5HTTLPR) was determined, and methylation ratios for each of the C-phosphate-G (CpG) residues were assessed using quantitative mass spectroscopy.

Author(s): 
van IJzendoorn, Marinus H.
Caspers, Kristin
Bakermans-Kranenburg, Marian J.
Beach, Steven R. H.
Philibert, Robert
Publication Title: 
Progress in Neuro-Psychopharmacology & Biological Psychiatry

Several diseases are known to have a multifactorial origin, depending not only on genetic but also on environmental factors. They are called "complex disorders" and include cardiovascular disease, cancer, diabetes, and neuropsychiatric and neurodegenerative diseases. In the latter class, Alzheimer's (AD) and Parkinson's diseases (PD) are by far the most common in the elderly and constitute a tremendous social and economical problem.

Author(s): 
Marques, Sueli C. F.
Oliveira, Catarina R.
Pereira, Claudia M. F.
Outeiro, Tiago F.
Publication Title: 
PloS One

BACKGROUND: Research suggests that the COMT Val(158)Met, BDNF Val(66)Met and OPRM1 A(118)G polymorphisms moderate the experience of pain. In order to obtain experimental confirmation and extension of findings, cortical processing of experimentally-induced pain was used. METHOD: A sample of 78 individuals with chronic low back pain complaints and 37 healthy controls underwent EEG registration. Event-Related Potentials were measured in response to electrical nociceptive stimuli and moderation by COMT Val(158)Met, BDNF Val(66)Met and OPRM1 A(118)G polymorphisms was assessed.

Author(s): 
Vossen, Helen
Kenis, Gunter
Rutten, Bart
van Os, Jim
Hermens, Hermie
Lousberg, Richel
Publication Title: 
L'Encephale

Kindling and behavioural sensitization were probably the first among the animal models of affective disorders, to suggest that genes-environment interactions were likely to be involved in the pathophysiology of these disorders. Cross-sensitization among stressors, drugs of abuse and illness episodes was deemed to be supported by the induction of a series of transcription factors, such as the proto-oncogene c-fos that subsequently alter gene expression by binding at DNA sites and inducing mRNAs for substances that may exert effects over long time periods.

Author(s): 
Azorin, J.-M.
Kaladjian, A.
Fakra, E.
Da Fonseca, D.
Adida, M.
Maurel, M.
Richieri, R.
Bottai, T.
Pringuey, D.
Publication Title: 
Journal of Psychiatric Research

We have recently shown that the expression of spermidine/spermine N1-acetyltransferase (SAT1) is downregulated across the brains of suicide completers, and that its expression is influenced by genetic variations in the promoter. Several promoter polymorphisms in SAT1, including rs6526342, have been associated with suicide and other psychiatric disorders, and display haplotype-specific effects on expression. However, these effects cannot explain total variability in SAT1 expression, and other regulatory mechanisms, such as epigenetic factors, may also be at play.

Author(s): 
Fiori, Laura M.
Turecki, Gustavo
Publication Title: 
Schizophrenia Research

INTRODUCTION: HTR2A gene has been the subject of numerous studies in psychiatric genetics because LSD, which resembles serotonin causes psychosis and atypical antipsychotic drugs target the HTR2A receptor. However, evidence for the role of HTR2A polymorphism(s) in schizophrenia (SCZ) and bipolar disorder (BD) has been elusive. We hypothesized that epigenetic dysregulation of HTR2A may be involved in psycho-pathogenesis and analyzed promoter DNA methylome and expression of HTR2A in SCZ, BD and control subjects.

Author(s): 
Abdolmaleky, Hamid Mostafavi
Yaqubi, Sahab
Papageorgis, Panagiotis
Lambert, Arthur W.
Ozturk, Sait
Sivaraman, Vadivelu
Thiagalingam, Sam
Publication Title: 
Harvard Review of Psychiatry

A principal weakness of evidence-based psychiatry is that it does not account for the individual variability in therapeutic response among individuals with the same diagnosis. The aim of personalized psychiatry is to remediate this shortcoming and to use predictors to select treatment that is most likely to be beneficial for an individual. This article reviews the evidence that genetic variation, environmental exposures, and gene-environment interactions shape mental illness and influence treatment outcomes, with a primary focus on depression.

Author(s): 
Uher, Rudolf
Publication Title: 
Phytotherapy research: PTR

The field of genetics, which includes the use of 'omic' technologies, is an evolving area of science that has emerging application in phytotherapy. Omic studies include pharmacogenomics, proteomics and metabolomics. Herbal medicines, as monotherapies, or complex formulations such as traditional Chinese herbal prescriptions, may benefit from omic studies, and this new field may be termed 'herbomics'.

Author(s): 
Sarris, Jerome
Ng, Chee Hong
Schweitzer, Isaac
Publication Title: 
Trends in Neurosciences

Addictions to cocaine or heroin/prescription opioids [short-acting ?-opioid receptor (MOPr) agonists] involve relapsing cycles, with experimentation/escalating use, withdrawal/abstinence, and relapse/re-escalation. ?-Opioid receptors (KOPr; encoded by OPRK1), and their endogenous agonists, the dynorphins (encoded by PDYN), have counter-modulatory effects on reward caused by cocaine or MOPr agonist exposure, and exhibit plasticity in addictive-like states. KOPr/dynorphin activation is implicated in depression/anxiety, often comorbid with addictions.

Author(s): 
Butelman, Eduardo R.
Yuferov, Vadim
Kreek, Mary Jeanne

Pages

Subscribe to RSS - Polymorphism, Genetic